ORF Biologics
Coralville, US · Founded 2024 · Iowa corporation
Find your way into ORF Biologics
Sign up to see every warm intro you have to ORF Biologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ORF Biologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
ST
Sara TernesExecutive
SH
Stephen HansonExecutive
AK

Anant KamathExecutiveAnant Kamath is Chief Executive Officer of ORF Biologics, which manufactures complex peptides, proteins, and antibodies in GLP and GMP environments. With nearly 40 years of experience in biologics and cellular engineering, he brings technical operations expertise in scaling production across multiple host systems.
NT
Nicholas TaiberNamed on SEC filing
RA
Roger A. BakerNamed on SEC filing
JR
John R. HuiskampNamed on SEC filing
Board
SM
Steven MichalicekBoard director
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 1 of 2 rounds · 2024–2026
▶$1.7MraisedJul 2026 · 17 investors · BiotechnologyRule 506(b)
▶$1.7MraisedJul 2026 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven MichalicekDirector
- Anant KamathExecutive Officer, Director
- Jay KamathExecutive Officer
- Sara TernesExecutive Officer
- Nicholas TaiberDirector
- Roger A. BakerDirector
- John R. HuiskampDirector
- Offering amount
- $2.5M
- Amount sold
- $1.7M
- First sale
- Jul 2026
- Incorporated
- Corporation, Iowa, 2024
- Federal exemptions
- 06b
▶$2.5MofferedDec 2024 · BiotechnologyRule 506(b)
▶$2.5MofferedDec 2024 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven MichalicekDirector
- Jay KamathExecutive Officer, Director
- Sara TernesExecutive Officer, Director
- Stephen HansonExecutive Officer, Director
- Anant KamathExecutive Officer, Director
- Offering amount
- $2.5M
- Minimum investment
- $50K
- Incorporated
- Corporation, Iowa, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ORF Biologics raised?
- ORF Biologics has disclosed $1.7M raised across 1 of its 2 known rounds.
- Where is ORF Biologics headquartered?
- ORF Biologics is headquartered in Coralville, US.
